Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : PDE5 Inhibitor or Phenethylamine or Stimulant

Use the filters below to narrow your results.

generic:
brand:
None (67) · Benzedrex (1) · Cialis, Adcirca (1) · Levitra, Staxyn (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1) · Stendra (1) · Viagra, Revatio (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (12) · Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · Potent 5-HT2A agonist (5) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2)
uses:
None (69) · '"`UNIQ--vote-00000040-QINU`"' (1) · '"`UNIQ--vote-00000669-QINU`"' (1) · '"`UNIQ--vote-00000705-QINU`"', '"`UNIQ--vote-00000706-QINU`"' (1) · '"`UNIQ--vote-00000738-QINU`"', '"`UNIQ--vote-00000739-QINU`"', '"`UNIQ--vote-0000073A-QINU`"' (1)
starting dose:
None (69) · 10 mg PRN; 2.5–5 mg daily for continuous coverage / BPH (1) · 10 mg ~1 h before sexual activity (1) · 100 mg ~15 min before sexual activity (1) · 50 mg ~1 h before sexual activity (ED); 20 mg TID (PAH) (1)
preparations:
None (69) · 2.5, 5, 10, 20 mg tabs (1) · 2.5, 5, 10, 20 mg tabs (Levitra); 10 mg ODT (Staxyn) (1) · 25, 50, 100 mg tabs (Viagra); 20 mg tabs and 10 mg/mL oral suspension (Revatio) (1) · 50, 100, 200 mg tabs (1)
fda max:
None (69) · 100 mg/d (ED); 20 mg TID (PAH) (1) · 20 mg/d (1) · 20 mg/d (ED, PRN); 5 mg/d (daily / BPH); 40 mg/d (PAH) (1) · 200 mg/d (100 mg/d if on CYP3A4 inhibitors) (1)
routes:
None (68) · insufflated (1) · IV (Revatio) (1) · Oral (5) · PR (1)
onset:
None (68) · 30 min (1) · 30–60 min (1) · 45-75 min (oral) (1) · ~15 min (fastest of the PDE5 inhibitors) (1) · ~30 min (1)
duration:
None (68) · 4-8 h (1) · 4–5 h (1) · 4–6 h (1) · Up to 36 h ("the weekend pill") (1) · ~4 h (1)
halflife:
None (68) · 4–5 h (1) · Not well characterized (1) · ~17.5 h (1) · ~4 h (1) · ~5 h (1)
bioavailability:
None (68) · Not well characterized (1) · Rapid absorption; absolute bioavailability not formally established (1) · Reasonable (not formally established as a percentage) (1) · ~15% (extensive hepatic first-pass) (1) · ~40% (1)
pregnancy:
None (68) · Category B (3) · Category C (not relevant; not used in women) (1) · Not established (1)
legal:
None (68) · Rx-only in US (4) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1)

Showing below up to 73 results in range #1 to #73.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"